Our perspective on the strategic role of sourcing and procurement articulated in articles, podcasts, and webinars.
With growing bipartisan support and after debate in both the US House and Senate, Life Science companies recognize the BIOSECURE Act has strong support to
By leveraging digital tools for supplier onboarding, collaboration and payment, CFOs can improve financial visibility, identify cost-saving opportunities and make informed decisions to optimize financial
With ongoing global inflation, rising interest rates, changing work environment and growing supply chain risks, CFOs are looking for efficient ways to work with their
Great procurement teams provide credible insights on supply costs and risks along with valuable insight on sourcing and supply management options.
Improving the odds of selecting the right CDMO for your organization requires an evaluation of market analysis, manufacturing and quality assessment, financial discussion, and several
Supply risk is what could happen to the production of a product, contract packager or third-party logistics (3PL) system —and they are now just as
The truth supply chain managers must face is that although the COVID pandemic was unprecedented, the disruptions it caused are not. The pandemic merely exposed
How a company structures its procurement and sourcing function will dictate how well it can work with suppliers to meet demanding customer and regulatory requirements.
Article
Building trust to be invited to the table of decision making
Podcast
Sourcing & Procurement support of marking and ad buying
Article
4 Steps to managing supply risk
Article
Many emerging life science companies are ill-equipped compared to larger companies to deal with major disruptions.
Co-written with Tunnell
Podcast
Importance of establishing a procurement and sourcing function for an emerging pharma company.
Co-written with Jonathan Horn
Article
Using COVID-19 to develop a supply risk framework.
Co-written with Bill Connell
Article
An interview with ISM about Managing supply risk.
Co-written with Bill Connell
Article
4 step framework to help emerging pharma companies select a CDMO
Co-written with Greg Anthos
Fill in the details below to be added to our quarterly newsletter.
